- Home
- RLJ vs XNCR Comparison
RLJ vs XNCR Comparison
Compare RLJ & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLJ
- XNCR
- Stock Information
- Founded
- RLJ 2011
- XNCR 1997
- Country
- RLJ United States
- XNCR United States
- Employees
- RLJ N/A
- XNCR N/A
- Industry
- RLJ Real Estate Investment Trusts
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- RLJ Real Estate
- XNCR Health Care
- Exchange
- RLJ Nasdaq
- XNCR Nasdaq
- Market Cap
- RLJ 1.5B
- XNCR 1.7B
- IPO Year
- RLJ 2011
- XNCR 2013
- Fundamental
- Price
- RLJ $9.92
- XNCR $19.24
- Analyst Decision
- RLJ Hold
- XNCR Strong Buy
- Analyst Count
- RLJ 7
- XNCR 9
- Target Price
- RLJ $10.92
- XNCR $36.33
- AVG Volume (30 Days)
- RLJ 1.7M
- XNCR 766.2K
- Earning Date
- RLJ 02-25-2025
- XNCR 02-25-2025
- Dividend Yield
- RLJ 5.04%
- XNCR N/A
- EPS Growth
- RLJ N/A
- XNCR N/A
- EPS
- RLJ 0.29
- XNCR N/A
- Revenue
- RLJ $1,359,502,000.00
- XNCR $85,164,000.00
- Revenue This Year
- RLJ N/A
- XNCR N/A
- Revenue Next Year
- RLJ $2.32
- XNCR $80.86
- P/E Ratio
- RLJ $34.36
- XNCR N/A
- Revenue Growth
- RLJ 3.89
- XNCR N/A
- 52 Week Low
- RLJ $8.74
- XNCR $15.31
- 52 Week High
- RLJ $12.39
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- RLJ 46.91
- XNCR 29.84
- Support Level
- RLJ $9.45
- XNCR $19.05
- Resistance Level
- RLJ $10.14
- XNCR $24.66
- Average True Range (ATR)
- RLJ 0.22
- XNCR 1.10
- MACD
- RLJ -0.02
- XNCR -0.49
- Stochastic Oscillator
- RLJ 53.45
- XNCR 3.26
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust that acquires focused-service and compact full-service hotels. Its portfolio consists of hotels in various states across the United States and the District of Columbia. Its hotels are under the Marriott, Hilton, and Hyatt brand names. These hotels are concentrated in urban areas, dense suburban markets, and business districts within metropolitan areas. Its revenue streams include hotel operations revenue, which is composed of the sale of rooms, food, and beverages, and other property revenue. The company derives the substantial majority of its revenue from the operation of hotels.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.